N/A
N=120
General or Regional Anesthesia for Hip Surgery
Osteoarthritis
Bottom Line
View on ClinicalTrials.gov: NCT01733472 ↗Enrolled (actual)
120
Serious AEs
0.0%
Results posted
Mar 2019
Primary outcome: Primary: Length of Hospital Stay — 30; 26 hours
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- GA-arm, remifentanil (Drug); RA-arm (Drug)
- Age
- Adult, Older Adult · 46+ yrs
- Sex
- All
- Sponsor
- Region Skane
- Primary completion
- Feb 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Length of Hospital Stay |
30; 26 | — |
| SECONDARY Post Operative Pain |
35; 25 | — |
Summary
The purpose of this study is to determine whether general anaesthesia or regional anaesthesia is best for patients undergoing Total Hip Arthroplasty.
Eligibility Criteria
Inclusion Criteria: patients with osteoarthritis scheduled for surgery
- patients that will require THA
- patients over 45 yrs and under 85 yrs.
- patients that understand the given information and are willing to participate in this study
- patients who have signed the informed consent document.
- patients belonging to ASA class I-III.
Exclusion Criteria
- prior surgery to the same hip
- patients with a history of stroke, neurological or psychiatric disease that potentially could affect the perception of pain
- obesity (BMI > 35)
- active or suspected infection
- patients taking opioids or steroids
- patients suffering from rheumatoid arthritis or an immunological depression
- patients who are allergic to any of the drugs being used in this study
Data sourced from ClinicalTrials.gov (NCT01733472). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.